Thursday, December 15, 2016

Alzheimer's: Proteomics gives clues toward alternatives to amyloid

In Alzheimer’s research, one particular protein looms large: plaque-forming amyloid-beta. Yet doctors now recognize that plaques can accumulate decades before symptoms appear. Recent clinical trials aimed at controlling or removing amyloid-beta have largely been disappointing.

from Dementia Big http://ift.tt/2hy6QNU via alcoholic dementia


http://ift.tt/2gPU24q

No comments:

Post a Comment